Precision Thoracic

Precision Thoracic is a private medical device company focused on minimally invasive thoracic intervention technologies rather than therapeutics. The company appears to be developing image-guided percutaneous devices for lung tissue excision, pulmonary nodule biopsy, and related chest-wall access and anesthetic delivery procedures. Publicly visible evidence is centered on patent filings and company-profile references, with limited evidence of commercial products, regulatory clearances, or human-stage therapeutic pipeline activity. Precision Thoracic has been associated with founders and executives including Richard J. Fischel and Edward M. Boyle, Jr. The company appears to operate in the lung cancer diagnosis and thoracic surgery ecosystem, with technology intended to improve early evaluation and treatment of suspicious pulmonary nodules.